Jairam Mediserve Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Revenue Growth %
- Profit Growth -78.15%
- Ebitda 91.42%
- Net Worth -64.04%
- Total Assets -5.69%
About Jairam Mediserve
Jairam Mediserve Private Limited (JMPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 September 2019 (Five years and five months 10 days old ). Its registered office is in Hooghly, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.00 M.
Arun Saha, Chandrima Saha, Sipra Saha, and One other member serve as directors at the Company.
Company Details
- Location
Hooghly, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909WB2019PTC233972
- Company No.
233972
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Jairam Mediserve?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Saha  | Director | 17-Sep-2019 | Current |
| Chandrima Saha | Director | 17-Sep-2019 | Current |
| Sipra Saha | Director | 17-Sep-2019 | Current |
| Abhishek Saha | Director | 17-Sep-2019 | Current |
Financial Performance of Jairam Mediserve.
Jairam Mediserve Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 78.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 64.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jairam Mediserve?
In 2021, Jairam Mediserve had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Dec 2022 | Hdfc Bank Limited | ₹3.00 M | Open |
How Many Employees Work at Jairam Mediserve?
Unlock and access historical data on people associated with Jairam Mediserve, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jairam Mediserve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jairam Mediserve's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.